Research have found that the level of interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) is significantly increased in the cerebrospinal fluid and peripheral blood of AD patients (Cattaneo et al., 2017). Here, TNF is linked to Alzheimer disease.